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Abstract
Background The ‘Clinical Pharmacists in General Practice’ (CPGP) pilot pro-
vided a template for general practice pharmacy professionals’ (GPPPs) roles
encouraging NHS England to fund >2000 practice-based pharmacists. However,
many GPPPs work outside the CPGP initiative and little is known about the
services they provide.
Objectives To explore services provided by all UK GPPPs (pharmacists/phar-
macy technicians), including the types of services, perceived benefits and barri-
ers to role development.
Methods A 26-item electronic questionnaire was developed using SurveyMon-
key and piloted during cognitive interviews. A cross-sectional survey was con-
ducted via social media, primary care organisations and emails to CPGP pilot
sites between November 2018 and March 2019. Three reminders were sent 1
week apart.
Key findings Ninety-one complete responses were received (81 pharmacists; 10
technicians). Over 80% of pharmacists provided clinical services, such as medi-
cation reviews or management of long-term conditions. More pharmacists
within CPGP pilot managed repeat prescribing requests (P = 0.035). Techni-
cians took responsibility for primarily non-clinical roles, including commission-
ing or safety alerts/drug recalls. A third of GPPPs wished to develop care home
services. Perceived benefits of GPPPs’ services included improved utilisation/de-
velopment of professional skills, identifying medicines-related issues and reduc-
tion in medication waste. Respondents were satisfied with professional
relationships but reported workload issues, limited patient awareness of their
roles and restricted opportunities to contribute to service development, which
was associated with unsatisfactory support/mentorship (P < 0.001).
Conclusion General practice pharmacy professionals deliver clinical and non-
clinical services which may benefit patients, general practice and the healthcare
system. General practices and national organisations should provide GPPPs
with tailored support and exploit the combined strengths of pharmacists and
pharmacy technicians to tackle increased workload.
Introduction
The UK National Health Service (NHS) is under consider-
able strain due to ongoing general practitioner (GP) work-
force crisis.[1,2] More than a half of GPs in England are
close to retirement age and 90% feel adversely affected by
increasing workload.[3] In order to alleviate these service
pressures, NHS England launched the ‘Clinical Pharmacists
in General Practice’ (CPGP) pilot, which part-funded 490
pharmacists with an aim of enhancing patients’ access to
general practice, supporting the management of long-term
conditions and improving communication between care
settings.[4–6] The success of phase 1 urged the Government
to invest £112 million into an additional 1500 pharmacists
to undertake largely patient-facing clinical roles contribut-
ing to the delivery of quality and outcomes framework
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(QOF) and a range of enhanced services.[5,7,8] The incep-
tion of Primary Care Networks (PCNs) committed to
future expansion and integration of these roles alongside
other allied healthcare professionals by 2024.[9,10]
Recent reports showed that pharmacists within CPGP
pilot felt well-integrated and engaged in a wide variety of
clinical and non-clinical roles.[5,11] Relatively, little is
known about practice-based pharmacists outside the NHS
England’s pilot. Early trials demonstrated that practice
pharmacist-led medication reviews may reduce polyphar-
macy and drug expenditure.[12–14] More recent research
involving general practice pharmacy professionals (GPPPs;
pharmacists and/or pharmacy technicians) reported
increased job satisfaction and a positive reception of their
roles by patients and colleagues.[15–18] Unfortunately,
these studies either recruited respondents with little-to-no
general practice experience[16,17] or focused on a single
professional group.[11,15,18]
A Scottish survey provided a fresh perspective on GPPPs’
roles and their successful integration.[19] However, its find-
ings might not be applicable elsewhere, for instance in Eng-
land where GPPP services are less well-established and
primarily funded by NHS England.[6] There is a need to
explore differences between GPPPs in England and services
provided by the whole workforce; both pharmacists within
and outside of the pilot; and also pharmacy technicians.
Upon reviewing the literature, one may hypothesise that
pharmacists within the NHS England’s scheme are less
experienced and assume different roles compared to either
those outside the pilot or to pharmacy technicians, for
example by delivering a wider range of services.[11,18,19] The
improved understanding of such differences may be essen-
tial for workforce planning and the future development
and integration of GPPPs’ roles in primary care.
This survey-based study aimed to explore the spectrum
of services provided by all UK GPPPs, including the types
of services delivered, the perceived barriers to role develop-
ment and the possible benefits to patients, surgeries, health-
care system and GPPPs themselves. In the absence of
published comparisons, it focused on differences between
the pharmacists within and outside the CPGP pilot and
between the pharmacists and practice-based technicians
who are becoming increasingly important for the effective
delivery of GPPP services.[17,18,20] The preliminary account
of study findings has been reported previously.[21]
Methods
Ethical approval
This study was approved by the Medway School of Phar-
macy Research Ethics Committee in September 2018
(REF01918).
Study design
This study was an open, voluntary, cross-sectional elec-
tronic survey developed using the SurveyMonkey platform
and was accessible to GPPPs in all four countries of the
UK. During November 2018–January 2019, the question-
naire was distributed via the Primary Care Pharmacy
Association (PCPA), social media pages (Twitter, Face-
book, LinkedIn) and direct emails to gatekeepers at gen-
eral practice surgeries/clinical commissioning groups in
Kent. In March 2019, the questionnaire was emailed to
362 CPGP pilot sites using the list published by NHS
England.[22] Three reminders, which included non-tar-
geted posts on social media, were sent 1-week apart for
each recruitment strategy.
Prior to questionnaire completion, each respondent
was provided with background information about the
study, including the purpose of the study, the length of
the questionnaire, the research team and data manage-
ment. They were then asked to confirm that they met the
eligibility criteria, that is registered UK pharmacist or
pharmacy technician, employed to provide professional
services within the surgery or on surgery’s behalf and not
employed exclusively to provide professional services[23]
in the dispensary or pharmacy within the surgery. Com-
pletion of the questionnaire implied a consent to partici-
pate. Prospective respondents were incentivised by an
opportunity to win a £20 Amazon voucher.
The likelihood of duplicate entries was minimised by
the in-built SurveyMonkey system to detect and register
respondent’s IP address, which prevented respondents
from completing the questionnaire twice using the same
device.
Questionnaire development
Individual questions were generated from pre-existing
GPPP research,[15–17,24,25] relevant NHS policies[6,7] and
CPGP service specification.[8] The draft questionnaire
(Appendix S1) was piloted during 30- to 40-min, face-to-
face or telephone cognitive interviews with a convenience
sample of five practice-based pharmacists (3 from South
East England, 1 – North East England and 1 – Wales).[26,27]
Following the interviews, a number of alterations were
introduced, for instance, by refining the variety of services
or amending the wording of Likert scale questions.
The revised questionnaire (Appendix S2) was approved
by five researchers and consisted of 26 items in four sec-
tions (1–4 questions per page, split across 19 screens): 6
single- or multiple-answer questions to capture the range
of services or clinical specialities and barriers to profes-
sional roles, 4 multiple-answer questions concerning the
benefits of services, two 5-point Likert scale items from
© 2020 The Authors. International Journal of Pharmacy Practice
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‘Strongly Agree’ to ‘Strongly Disagree’ relating to profes-
sional role and practice relationships (10 and 12 statements,
respectively) and 14 single- or multiple-answer questions to
ascertain respondents’ demographics. Participants were
able to add comments throughout the questionnaire.
Adaptive questioning was used in certain question
items to explore specific responses, for example the per-
centage of time spent delivering services which were
selected in a previous question. Mandatory items on each
screen had to be answered before participants were
allowed to progress; however, they were able to review
their answers prior to submitting the questionnaire.
Data analysis
The data of respondents who answered at least one
mandatory question were included in the analysis. Follow-
ing an automatic data extraction from SurveyMonkey, all
data were stored on a password-protected network within
the University of Kent. All questionnaire data were
anonymous, although respondents were able to voluntar-
ily provide their email addresses to enter the prize draw.
These email addresses were kept separate from the rest of
the data and were permanently deleted once the draw was
complete. Statistical analysis was conducted using SPSS
(v25, International Business Machines Corporation
(IBM), Armonk, New York, USA). Descriptive data were
expressed as the number of respondents (% of total).
Between-group differences or associations for categorical
variables were determined using Pearson’s chi-square or
Fisher’s exact tests with Freeman–Halton extension (for
contingency tables larger than 2x2)[28] followed by Bon-
ferroni corrections where appropriate. Data underpinning
each association are presented in the Appendix S3. Statis-
tical significance was set at P < 0.05.
Results
Respondents
A total of 105 professionals responded to the question-
naire (91 complete responses; completion rate 86.7%).
Most respondents were located in London or the South
East of England (47.3%, 43/91) followed by South West
of England (18.7%, 17/91), East Midlands, North East of
England and West Midlands (6.6%, 6/91 each). Four
responses (4.4%) were received from Wales and 1 (1.1%)
from Scotland. GPPPs were predominantly pharmacists
(89.0%, 81/91), and a quarter (26.4%, 24/91) had
>20 years of experience (Table 1). The majority had
worked in general practice for ≤5 years (85.7%, 78/91)
originating from either community (80.2%, 73/91) or
hospital pharmacy (51.7%, 47/91) backgrounds.
Fifty-eight per cent of pharmacists (47/81) were
employed within the CPGP pilot. No significant demo-
graphic differences between CPGP pilot pharmacists and
those employed outside the scheme were observed
although those outside the pilot were somewhat older and
a higher proportion was male. Compared to pharmacists,
pharmacy technicians had more general practice experi-
ence (Fisher’s exact test, P = 0.019) and were more likely
to come from a less traditional professional background,
such as clinical research (Fisher’s exact test, P = 0.016).
At the time of survey, 76.5% of pharmacists (62/81) had
completed or were completing an independent prescribing
qualification. Slightly more pharmacists within than out-
side the pilot had completed or were completing a pre-
scribing qualification even though the difference was not
significant (80.9%, 38/47 vs. 70.6%, 24/34).
Professional services
Over 70% of GPPPs (74/104) had no particular clinical
speciality. A quarter specialised in cardiology (27.9%, 29/
104) or care of the elderly (25.0%, 26/104). Diabetes
and endocrinology were the most popular choices for
developing a future speciality (36.2%, 34/94) followed by
cardiology (34.0%, 32/94) and mental health (31.9%, 30/
94).
Each participant provided an average of 9.1 services
(95% confidence intervals (CI) 8.3–9.9; n = 104). The
most common services provided by all GPPPs are
shown in Figure 1. Pharmacists commonly engaged in
medication reviews (91.4%, 74/81), management of
polypharmacy (84.0%, 68/81), medicines reconciliation/
transfer of care or management of long-term conditions
(81.5%, 66/81 each) and audits (72.8%, 59/81). There
were few statistically significant associations between dif-
ferent services and the three groups of GPPPs. Those
within the pilot were more likely than others to be
managing repeat prescribing requests (70.2%, 33/47 vs.
47.1%, 16/34; v2 = 4.4, df = 1, P = 0.035). Nine out of
10 pharmacy technicians liaised with commissioners, 8
– managed safety alerts/drug recalls, developed/imple-
mented standard operating procedures (SOPs) or pro-
vided education/training. Regarding patient-facing roles,
seven pharmacy technicians provided medicines recon-
ciliation/transfer of care services, six managed repeat
prescribing requests or domiciliary visits and five deliv-
ered medication reviews.
Nearly one in five of GPPPs (18.9%, 18/95) spent
>50% of their time providing medication reviews fol-
lowed by the management of long-term conditions
(14.7%, 14/95), management of polypharmacy (12.6%,
12/95) and repeat prescribing requests (11.6%, 11/95)
(Figure 2). Services requiring the least time (≤5%) were
International Journal of Pharmacy Practice 2020, , pp. – © 2020 The Authors. International Journal of Pharmacy Practice
published by John Wiley & Sons Ltd on behalf of Royal Pharmaceutical Society
Vilius Savickas et al. 3
the management of safety alerts/drug recalls (52.6%, 50/
95), audits (48.4%, 46/95) and development/implementa-
tion of SOPs (43.2%, 41/95).
Care home visits (32.9%, 25/76), the management of
common or minor ailments/injuries (25.0%, 19/76) and
anticoagulation services (17.1%, 13/76) were the leading
choices of future services. Technicians wished to be more
involved in medication reviews (50%, 5/10 vs. 0% of
pharmacists; Fisher’s exact test, P < 0.001).
Benefits and barriers
The most common perceived benefits of GPPP services
included the better utilisation of pharmacy professionals’
skills (92.7%, 89/96), identifying medicines-related issues
(91.7%, 88/96), development of new knowledge and skills
(90.6%, 87/96) and a reduction in medication waste
(90.6%, 87/96) (Figure 3). Significantly fewer pharmacy
technicians than pharmacists felt that their services
improved patient access to health care (Fisher’s exact test,
P = 0.012) or treatment outcomes (Fisher’s exact test,
P < 0.001), or reduced inappropriate polypharmacy (Fish-
er’s exact test, P = 0.01) or the rate of hospitalisations
(Fisher’s exact test, P = 0.036). Lack of time (57.9%, 55/
95), workload (54.7%, 52/95) and inadequate funding
(45.3%, 43/94) stood out as the key barriers to working
in practices and role development. Pharmacists pointed
out the difficulties of covering ‘too many practices’ and














Male 26 (28.6) 12 (25.5) 12 (35.3%) 2 (20.0)
Female 63 (69.2) 35 (74.5) 20 (58.8%) 8 (80.0)
Prefer not to say 2 (2.2) 0 (0.0) 2 (5.9%) 0 (0.0)
Age groups, years, n (%)
<25 3 (3.3) 2 (4.3) 1 (2.9%) 0 (0.0)
25–34 35 (38.5) 21 (44.7) 13 (38.2%) 1 (10.0)
35–44 32 (35.2) 15 (31.9) 13 (38.2%) 4 (40.0)
45–54 17 (18.7) 9 (19.1) 4 (11.8%) 4 (40.0)
55–65 4 (4.4) 0 (0.0) 3 (8.8%) 1 (10.0)
Experience as a pharmacy professional (years), n (%)
<1 1 (1.1) 0 (0.0) 1 (2.9%) 0 (0.0)
1–5 15 (16.5) 11 (23.4) 3 (8.8%) 1 (10.0)
6–10 21 (23.1) 10 (21.3) 8 (23.5%) 3 (30.0)
11–15 22 (24.2) 11 (23.4) 9 (26.5%) 2 (20.0)
16–20 8 (8.8) 4 (8.5) 3 (8.8%) 1 (10.0)
>20 24 (26.4) 11 (23.4) 10 (29.4%) 3 (30.0)
Experience in general practice (years), n (%)
<1 22 (24.2) 13 (27.7) 8 (23.5%) 1 (10.0)
–5 56 (61.5) 31 (66.0) 22 (64.7%) 3 (30.0)
6–10 6 (6.6) 2 (4.3) 1 (2.9%) 3 (30.0)*
11–15 4 (4.4) 1 (2.1) 1 (2.9%) 2 (20.0)
16–20 2 (2.2) 0 (0.0) 1 (2.9%) 1 (10.0)
>20 1 (1.1) 0 (0.0) 1 (2.9%) 0 (0.0)
Experience in other sectors, n (%)
Community pharmacy 73 (80.2) 39 (83.0) 27 (79.4%) 7 (70.0)
Hospital pharmacy 47 (51.7) 25 (53.2) 16 (47.1%) 6 (60.0)
Commissioning of services 30 (33.0) 12 (25.5) 14 (41.2%) 4 (40.0)
Academia 8 (8.8) 4 (8.5) 3 (8.8%) 1 (10.0)
Pharmaceutical industry 7 (7.7) 5 (10.6) 2 (5.9%) 0 (0.0)
Prison pharmacy 4 (4.4) 3 (6.4) 1 (2.9%) 0 (0.0)
Online pharmacy 3 (3.3) 2 (4.3) 1 (2.9%) 0 (0.0)
Other 8 (8.8) 4 (8.5) 0 (0.0%) 4 (40.0)**
CPGP, ‘Clinical Pharmacists in General Practice’ (NHS England’s pilot scheme).
*P = 0.019 and
**P = 0.016 for differences between pharmacist and technician respondents determined using Fisher’s exact tests.
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Figure 1 Current and future services indicated by respondents to the survey. SOPs, standard operating procedures.
Figure 2 Proportion of average weekly time spent delivering services. SOPs, standard operating procedures; QOF, quality and outcomes frame-
work.
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the impact of ‘managing repeat medication re-authorisa-
tion’ on their workload.
The majority of respondents felt adequately trained
(79.4%, 73/92) and supported/mentored (73.9%, 68/92).
One pharmacist highlighted the absence of ‘formal net-
works of practice pharmacists’ and ‘poor support’ from
their professional body. Although most respondents were
confident/competent in their professional roles (85.9%,
79/92), only 40.2% (37/92) had sufficient opportunity to
contribute towards the development of services. This per-
ception was greater amongst those with inadequate sup-
port/mentorship (Fisher’s exact test, P < 0.001). Despite
this, respondents were satisfied with their contribution to
patient outcomes, work/development of the practice, the
functioning/development of the wider healthcare system
and GPPPs roles (>75% agreement each). Only 58.7% of
GPPPs (54/92) were satisfied with the amount of time
given to complete their daily tasks. Paradoxically, more
respondents perceived that they had a good work-life bal-
ance (77.2%, 71/92).
General practice pharmacy professionals were overall
satisfied with their working relationships, perceived value
of their services and the level of trust from patients, GPs
and other healthcare professionals (>80% agreement
each). GPPPs who reported good relationships with GPs
were more likely to feel satisfied with their level of men-
torship/support (Fisher’s exact test, P = 0.029). Three-
quarters of respondents (71/92) thought that GPs were
aware of services they provided compared to 57.6%
awareness by other healthcare professionals (53/92) or
43.5% by patients (40/92). Respondents who indicated
low patient awareness were less likely to have good
patient–professional relationships (Fisher’s exact test,
P = 0.019) or feel confident/competent in their roles
(Fisher’s exact test, P = 0.009).
Over 90% of GPPPs wished to remain in the field by
2024 either by working within the same surgery (61.5%,
56/91) or by moving to a different surgery (23.1%, 21/
91). A smaller proportion was undecided (16.5%, 15/91)
or had unlisted career options in mind (8.8%, 8/91), for
example, becoming a partner at their surgery. Satisfactory
support/mentorship was associated with a choice to
remain within the same surgery (v2 = 16.7, df = 2,
P < 0.001).
Discussion
This cross-sectional survey investigated the services pro-
vided by UK GPPPs, including the types of services, per-
ceived benefits for stakeholders and barriers to role
development, while comparing practice-based pharmacists
and pharmacy technicians as well as pharmacists within
and outside the CPGP pilot scheme. Clinical activities,
such as management of patients with long-term condi-
tions or polypharmacy, remained the key services amongst
all practice-based pharmacists, although significantly more
pharmacists within the NHS England’s pilot managed
repeat prescribing requests. As anticipated, pharmacy
Figure 3 Key perceived benefits of
general practice pharmacy services
and barriers to role development or
working in general practice.
© 2020 The Authors. International Journal of Pharmacy Practice
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technicians engaged in primarily administrative or techni-
cal tasks hoping to become more involved in the future
delivery of medication reviews. Respondents suggested
that GPPP services may improve patient safety, practice
capacity and cost-effectiveness of medicines while helping
to advance their relatively new professional roles. Insuffi-
cient time/funding and workload were the primary barri-
ers to GPPP roles, yet respondents also highlighted issues
concerning role awareness and restricted contribution to
service development.
The broad inclusion criteria provided this study with
unique comparisons between general practice pharmacists
and pharmacy technicians and, for the first time, between
pharmacists within and outside the CPGP scheme. How-
ever, the sampling approach was England centric, and
therefore, very few participants were recruited from the
devolved nations. This given the differences in organisa-
tion and healthcare policy between nations and the low
response rate generally from pharmacy technicians and
GPPPs outside of London and the South East limits the
generalisability of the findings.
Despite this setback, respondent demographics and the
range of professional services ascertained by this survey
were comparable to surveys of CPGP pharmacists and
Scottish GPPPs, which suggested that those within the
pilot were slightly (albeit not significantly) younger and
possibly less experienced than other GPPPs.[11,19] We
also found that 70% of pharmacists within the NHS
England’s scheme managed repeat prescribing requests
compared to only 47% of those outside the pilot even
though no differences were observed in the proportion
of time spent delivering this service. Two-thirds of all
primary care prescriptions are repeated, resulting in
2.7 million GP hours per year.[29] The results presented
here imply that organisations participating in the NHS
England’s pilot may have utilised the new GPPPs’ roles
to help reduce this repeat prescription burden, while
such a strategy may be far less common amongst the
organisations external to the scheme. Over 75% of
responding pharmacists were prescribers, and more than
1 in 10 spent >50% of their time managing repeat pre-
scription requests, urging the general practice employers
to find the correct balance between this life-saving task
for GPs and other essential services of medicines optimi-
sation previously detailed in the NHS England’s service
specification.[8] Six pharmacy technicians were also
engaged in repeat prescribing service, possibly by assist-
ing with non-clinical aspects of this time-consuming
task, such as prescription collection or manage-
ment.[17,18,20] Similar to previous reports,[18,19] some
technicians were involved in patient-facing activities,
including medication reviews, advocating for their role
as an asset to efficient pharmacist-led clinical services.
Nearly 60% of GPPPs reported the lack of time or
workload as a barrier to their roles. This issue was raised
by UK and Australian qualitative studies[17,30] and should
be a priority to prevent a professional burnout experi-
enced by GPs.[31] Although affected by time constraints,
the majority of GPPPs were surprisingly pleased with
their work–life balance, which may be related to more
flexible working hours compared to either community or
hospital pharmacy.[32,33] Most pharmacists had prior
community pharmacy experience; therefore, this contra-
dictory finding may also reflect a recent transition from
the mentally draining, ‘in-charge’ community pharma-
cist’s role to the less managerial general practice
post.[32,34]
The request for more GP support amongst CPGP par-
ticipants[11] was replicated in this study, which implied
that inadequate support or mentorship could be over-
come through improved GPPP-GP relationships. In turn,
the findings hinted that better support/mentorship may
increase staff retention and reduce the perceived ‘restric-
tion to contribute’. Resembling other studies,[17,35] some
respondents highlighted the low GPPP service awareness
amongst patients, which was associated with poor work-
ing relationships and low self-confidence. According to
the qualitative study by Tan et al.,[30] such effects are
likely to be temporary as GPPPs settle into new roles and
demonstrate their professional capabilities. At the time of
the survey, 85% of respondents had worked in general
practice for 5 years or less indicating the large amount of
further work to be completed when raising awareness of
their roles amongst the public and other healthcare pro-
fessionals. Indeed, as pointed out by one of the respon-
dents, national organisations, such as the PCPA, the
Royal Pharmaceutical Society and the Royal College of
General Practitioners, will continue to play a major role
both in this awareness-raising process and in providing
GPPPs with adequate centralised support or mentorship
mechanisms.
Service benefits identified by GPPPs compared to both
early trials[12-14] and more recent qualitative stud-
ies[5,16,17,30,36] showing that GPPPs’ actions may produce
cost-savings, reduce GP workload, improve patients’
knowledge/adherence to treatment, safeguard patient
safety and help utilise pharmacy skills. Interestingly, phar-
macy technicians were more sceptical about such benefits
than pharmacists, which may be due to more extensive
general practice experience[37] or a smaller focus on clini-
cal services.[20]
Overall, the 5-year future of general practice pharmacy
is bright with a predicted >90% staff retention rate and a
30% expansion of care home services in line with the
NHS agenda, which may be a subject of future stud-
ies.[9,38,39] The growth of other services, such as
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anticoagulation or management of long-term conditions,
matched the future cardiology/endocrinology specialities
reflecting the national cardiovascular priorities and the
roles of GPPPs within the emerging PCNs.[40,41] The
>20% increase in GPPP-led common/minor ailment ser-
vices was unanticipated considering the Government’s
strategy for community pharmacies to become the first
port of call in minor urgent care.[9,42] While that could
be an attempt to tackle the ‘incessant’ demand for acute
prescriptions,[43] future research may wish to explore any
other reasons underlying this discrepancy.
Conclusion
The findings of this cross-sectional survey showcased the
diverse range of current and future services provided by
GPPPs across the UK. Practice-based pharmacists and
pharmacy technicians engaged in a variety of clinical and
non-clinical roles displaying a synergistic relationship
which may benefit multiple stakeholders while helping
overcome the barriers such as increased workload at the
time of general practice workforce crisis. To our knowl-
edge, this study was the first of its kind to report a com-
parison between practice-based pharmacists within and
outside the CPCP pilot, exposing the possible divergence
of their job roles, for instance, the distinct focus on repeat
prescribing services within the NHS England’s scheme.
Last but not least, this research emphasised the signifi-
cance of adequate GP-GPPP relationships and support/
mentorship mechanisms, which together with knowledge
of barriers to role development, may be pivotal to the
future growth of this branch of pharmacy profession and
to effective GPPPs’ integration within the constantly
evolving primary care structures.
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